Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000024503 | SCV000589427 | uncertain significance | not provided | 2020-01-28 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 31810; Landrum et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 18006477, 32880476) |
Labcorp Genetics |
RCV000698832 | SCV000827521 | uncertain significance | Dilated cardiomyopathy 1KK | 2024-11-19 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 881 of the MYPN protein (p.Asn881Ile). This variant is present in population databases (rs71584493, gnomAD 0.008%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 32880476). ClinVar contains an entry for this variant (Variation ID: 31810). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV000024503 | SCV001716066 | uncertain significance | not provided | 2021-01-08 | criteria provided, single submitter | clinical testing | |
Leiden Muscular Dystrophy |
RCV000024503 | SCV000045807 | not provided | not provided | 2012-04-27 | no assertion provided | curation | |
Blueprint Genetics | RCV000157383 | SCV000207121 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2014-03-03 | no assertion criteria provided | clinical testing |